ClinicalTrials.Veeva

Menu

Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical Cystectomy (CirCanCell)

A

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

Status

Completed

Conditions

Bladder Cancer
Circulating Tumor Cells

Treatments

Genetic: Detection of circulating tumor cells in blood samples

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Very few factors may be identified as prognostic for patients with bladder cancer undergoing radical cystectomy. Recently, detection of circulating tumor cells has shown to be very promising in anticipating both the likelyhood of distant metastases and survival in patients with breast cancer, melanoma, prostate cancer and other malignancies. In the present study we both tested the detection rate of circulating tumor cells using a PCR based methodology in the peripheral blood of patients undergoing radical cystectomy, and we further correlated our results with their clinical outcome.

Enrollment

59 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Prior trans urethral resection of the bladder (TUR)
  • Histological confirmation of a transitional cell carcinoma (TCC) of the bladder
  • ECOG Performance Status ≤ 2
  • WBC count ≥4,000/μL; platelet count ≥150,000/μL; creatinine ≤1.8 mg/dL; AST, ALT, and alkaline phosphatase ≤2X the upper limit of normal, normal total bilirubin
  • recent (within 6 weeks of cystectomy) total body CT imaging study excluding distant metastases as well as upper urinary tract TCC

Exclusion criteria

  • Neo-adjuvant chemotherapy (either planned or already performed)
  • Patients receiving investigational medications
  • Subjects not suitable for a radical cystectomy
  • Patients not willing to participate

Trial design

59 participants in 2 patient groups

Cystectomy patients
Description:
Arm of patients undergoing radical cystectomy for bladder cancer providing peripheral blood samples for detection of circulating cancer cells
Treatment:
Genetic: Detection of circulating tumor cells in blood samples
Healthy volunteers
Description:
Arm of healthy subjects not undergoing radical cystectomy providing peripheral blood samples for detection of circulating cancer cells
Treatment:
Genetic: Detection of circulating tumor cells in blood samples

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems